IMMUNOVANT, INC. Income Taxes Paid
IMMUNOVANT, INC. (IMVT) reported Income Taxes Paid of $2.39 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-05-20
- IMMUNOVANT, INC. income taxes paid for the quarter ending 2026-03-31 was -$51.00K, a 105.66% decline year-over-year.
- IMMUNOVANT, INC. income taxes paid for the quarter ending 2025-12-31 was $1.64M.
- IMMUNOVANT, INC. income taxes paid for the quarter ending 2025-03-31 was $901.00K, a 77.01% increase year-over-year.
- IMMUNOVANT, INC. income taxes paid for the quarter ending 2024-12-31 was $0.00.
- IMMUNOVANT, INC. income taxes paid for fiscal 2026 was $2.39M, a 98.50% increase from fiscal 2025.
- IMMUNOVANT, INC. income taxes paid for fiscal 2025 was $1.20M, a 136.15% increase from fiscal 2024.
- IMMUNOVANT, INC. income taxes paid for fiscal 2024 was $509.00K.
- IMMUNOVANT, INC. income taxes paid for fiscal 2023 was $0.00.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $1.58M derived: sum of 2 quarters · filed 2026-05-20 | $2.39M 10-K · filed 2026-05-20 | |
| 2025-12-31 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $2.44M 10-Q · filed 2026-02-06 | ||
| 2025-09-30 | $801.00K 10-Q · filed 2025-11-10 | |||
| 2025-03-31 | $901.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $901.00K derived: sum of 2 quarters · filed 2026-05-20 | $1.20M 10-K · filed 2026-05-20 | |
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $301.00K 10-Q · filed 2026-02-06 | ||
| 2024-09-30 | $301.00K 10-Q · filed 2025-11-10 | |||
| 2024-03-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $509.00K derived: sum of 2 quarters · filed 2026-05-20 | $509.00K 10-K · filed 2026-05-20 | |
| 2023-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | $0.00 10-Q · filed 2025-02-06 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |||
| 2023-03-31 | $0.00 10-K · filed 2025-05-29 | |||
| 2022-03-31 | $0.00 10-K · filed 2022-06-08 | |||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-08 | $74.00K derived: sum of 2 quarters · filed 2022-06-08 | $166.00K 10-K · filed 2022-06-08 | |
| 2020-12-31 | $74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $166.00K 10-Q · filed 2021-02-16 | ||
| 2020-09-30 | $92.00K 10-Q · filed 2020-11-12 | |||
| 2020-03-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-01 | $61.00K derived: sum of 2 quarters · filed 2021-06-01 | $61.00K 10-K · filed 2021-06-01 | |
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $173.25K 10-Q · filed 2019-11-13 | ||
| 2019-03-31 | $68.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |